Clinical trial
FDDNP-PET for in vivo diagnosis of Tauopathy in unclassifiable parkinsonism
To assess the ability to detect in vivo underlying tau pathology in unclassifiable parkinsonism by means of [18F]-FDDNP
Category | Value |
---|---|
Study start date | 2012-08-09 |